| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Scholar Rock Holding Corporation (NASDAQ: SRRK)
SRRK Technical Analysis
5
| As on 9th Jun 2023 SRRK STOCK Price closed @ 7.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 11.07 & Strong Sell for SHORT-TERM with Stoploss of 19.77 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SRRKSTOCK Price
| Open | 6.99 | Change | Price | % |
| High | 7.29 | 1 Day | 0.06 | 0.86 |
| Low | 6.77 | 1 Week | 1.21 | 20.90 |
| Close | 7.00 | 1 Month | -0.18 | -2.51 |
| Volume | 193353 | 1 Year | -19.17 | -73.25 |
| 52 Week High 26.66 | 52 Week Low 4.66 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| SRRK Daily Charts |
SRRK Intraday Charts |
Whats New @ Bazaartrend |
SRRK Free Analysis |
|
|
SRRK Important Levels Intraday
| RESISTANCE | 8.00 |
| RESISTANCE | 7.68 |
| RESISTANCE | 7.48 |
| RESISTANCE | 7.28 |
| SUPPORT | 6.72 |
| SUPPORT | 6.52 |
| SUPPORT | 6.32 |
| SUPPORT | 6.00 |
SRRK Forecast May 2024
| 4th UP Forecast | 23.65 |
| 3rd UP Forecast | 18.31 |
| 2nd UP Forecast | 15.01 |
| 1st UP Forecast | 11.71 |
| 1st DOWN Forecast | 2.29 |
| 2nd DOWN Forecast | -1.01 |
| 3rd DOWN Forecast | -4.31 |
| 4th DOWN Forecast | -9.65 |
SRRK Weekly Forecast
| 4th UP Forecast | 13.07 |
| 3rd UP Forecast | 11.12 |
| 2nd UP Forecast | 9.92 |
| 1st UP Forecast | 8.72 |
| 1st DOWN Forecast | 5.28 |
| 2nd DOWN Forecast | 4.08 |
| 3rd DOWN Forecast | 2.88 |
| 4th DOWN Forecast | 0.93 |
SRRK Forecast2024
| 4th UP Forecast | 51.17 |
| 3rd UP Forecast | 37 |
| 2nd UP Forecast | 28.25 |
| 1st UP Forecast | 19.49 |
| 1st DOWN Forecast | -5.49 |
| 2nd DOWN Forecast | -14.25 |
| 3rd DOWN Forecast | -23 |
| 4th DOWN Forecast | -37.17 |
Scholar Rock Holding Corporation ( NASDAQ USA Symbol : SRRK )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SRRK Business Profile
Scholar Rock Holding Corporation, a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, a novel inhibitor of the activation of latent myostatin that has completed the Phase II clinical trials for the treatment of spinal muscular atrophy; and SRK-181, which is in Phase I clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is also developing a pipeline of novel product candidates with potential to transform the lives of patients suffering from a range of serious diseases, including neuromuscular disorders, cancer, and fibrosis. The company has a collaboration agreement with Gilead Sciences, Inc. to discover and develop specific inhibitors of transforming growth factor beta activation for the treatment of fibrotic diseases. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts. Address: 301 Binney Street, Cambridge, MA, United States, 02142
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service